par Kern, Winfried V.;Marchetti, Oscar;Drgona, Lubos;Akan, Hamdi;Aoun, Mickel;Akova, Murat;De Bock, Robrecht;Paesmans, Marianne
;Viscoli, Claudio;Calandra, Thierry
Référence Journal of clinical oncology, 31, 9, page (1149-1156)
Publication Publié, 2013-03
;Viscoli, Claudio;Calandra, ThierryRéférence Journal of clinical oncology, 31, 9, page (1149-1156)
Publication Publié, 2013-03
Article révisé par les pairs
| Titre: |
|
| Auteur: | Kern, Winfried V.; Marchetti, Oscar; Drgona, Lubos; Akan, Hamdi; Aoun, Mickel; Akova, Murat; De Bock, Robrecht; Paesmans, Marianne; Viscoli, Claudio; Calandra, Thierry |
| Informations sur la publication: | Journal of clinical oncology, 31, 9, page (1149-1156) |
| Statut de publication: | Publié, 2013-03 |
| Sujet CREF: | Cancérologie |
| MeSH keywords: | Administration, Oral |
| Adolescent | |
| Adult | |
| Aged | |
| Amoxicillin -- administration & dosage -- adverse effects | |
| Anti-Bacterial Agents -- administration & dosage | |
| Anti-Infective Agents -- administration & dosage | |
| Aza Compounds -- administration & dosage -- adverse effects | |
| Ciprofloxacin -- administration & dosage -- adverse effects | |
| Clavulanic Acid -- administration & dosage -- adverse effects | |
| Double-Blind Method | |
| Drug Combinations | |
| Female | |
| Fever -- drug therapy | |
| Fluoroquinolones | |
| Humans | |
| Injections, Intravenous | |
| Male | |
| Middle Aged | |
| Neoplasms -- complications | |
| Neutropenia -- complications | |
| Quinolines -- administration & dosage -- adverse effects | |
| Risk Factors | |
| Treatment Outcome | |
| Note générale: | SCOPUS: ar.j |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0732-183X |
| info:doi/10.1200/JCO.2012.45.8109 | |
| info:pii/JCO.2012.45.8109 | |
| info:scp/84876000769 | |
| info:pmid/23358983 |



